×
About 4,920 results

ALLMedicine™ Aortic Regurgitation Center

Research & Reviews  1,717 results

Surgical treatment of recurrent subvalvular discrete membrane and left ventricular outf...
https://doi.org/10.1111/echo.15531
Echocardiography (Mount Kisco, N.Y.); Kahraman N, Topal D et. al.

Feb 2nd, 2023 - Left ventricular outflow stenosis can develop at the supravalvular, valvular, and subvalvular levels. Resection of strictures at the diffuse subvalvular level is very difficult. In such pathologies, Konno-Rastan procedure provides very successful ...

Bicuspid aortic valve associated aortopathy: 2022 guideline update.
https://doi.org/10.1097/HCO.0000000000001020
Current Opinion in Cardiology; Verma R, Cohen G et. al.

Feb 1st, 2023 - Bicuspid aortic valve (BAV) disease is observed in 1-2% of the general population. In addition to valve-related complications (such as aortic stenosis and aortic regurgitation), individuals with BAV often develop dilatation of the proximal aorta (...

The ReDo-TAVI Prospective Observational Registry
https://clinicaltrials.gov/ct2/show/NCT05601453

Jan 27th, 2023 - Between 1.4 and 2.8% of all patients undergoing transcatheter heart valve (THV) implantation require a second THV implanted into the previously implanted THV because of clinically significant aortic regurgitation [1-3]. 90% of THV-in-THV implants ...

Transfemoral Perimembranous Ventricular Septal Defect Device Closure in Infants Weighin...
https://doi.org/10.1007/s00246-023-03100-5
Pediatric Cardiology; Alshahrani D, Linnane N et. al.

Jan 26th, 2023 - Transcatheter closure of Perimembranous VSDs (PMVSD) remains challenging particularly in infants. The aim of this study is to evaluate the efficacy and safety of transfemoral PMVSD device closure in infants weighing ≤ 10 kg in a single centre. Ret...

Reasons for disagreement between screening and standard echocardiography in primary car...
https://doi.org/10.1007/s10554-023-02800-6
The International Journal of Cardiovascular Imaging; Galdino BF, Amaral AM et. al.

Jan 22nd, 2023 - We aimed to evaluate the reasons for disagreement between screening echocardiography (echo), acquired by nonexperts, and standard echo in the Brazilian primary care (PC). Over 20 months, 22 PC workers were trained on simplified handheld (GE VSCAN)...

see more →

Clinicaltrials.gov  72 results

The ReDo-TAVI Prospective Observational Registry
https://clinicaltrials.gov/ct2/show/NCT05601453

Jan 27th, 2023 - Between 1.4 and 2.8% of all patients undergoing transcatheter heart valve (THV) implantation require a second THV implanted into the previously implanted THV because of clinically significant aortic regurgitation [1-3]. 90% of THV-in-THV implants ...

PROVE ACURATE neo2™ - Post Market Safety and Performance Surveillance in Aortic Stenosis
https://clinicaltrials.gov/ct2/show/NCT05539573

Jan 12th, 2023 - There are four leading causes of valvular aortic valve stenosis, namely: calcific aortic stenosis, congenital aortic valve malformations, rheumatic aortic valve stenosis, and endocarditis. Calcific aortic valve stenosis is a chronic progressive di...

TAVIS Registry - Trilogy Heart Valve System for Management of Patients With Aortic Valve Disease
https://clinicaltrials.gov/ct2/show/NCT05536310

Jan 11th, 2023 - Aortic stenosis (AS) is a narrowing of the aortic valve opening causing restricted blood flow from the left ventricle to the aorta and may also affect the pressure in the left atrium. Aortic regurgitation (AR) is a condition where the aortic valve...

Follow up of Moderate Aortic Regurge After Mitral Valve Replacement
https://clinicaltrials.gov/ct2/show/NCT05680610

Jan 11th, 2023 - A considerable proportion of patients who require mitral valve replacement present with a coexisting pathology of the aortic valve (AV). Rheumatic fever remains the leading cause for combined disease (1) Early series found that one-third of rheuma...

THE ALIGN-AR EFS TRIAL: JenaValve Pericardial TAVR Aortic Regurgitation Study
https://clinicaltrials.gov/ct2/show/NCT02732704

Nov 18th, 2022 - This study will examine the use of TAVR (Transcatheter Aortic Valve Replacement), which is a minimally invasive procedure designed to replace the aortic valve inside the heart. In this study, TAVR will be performed using the JenaValve Pericardial ...

see more →

News  173 results

JenaValve Trilogy Takes Another Step Forward in Severe AR
https://www.medscape.com/viewarticle/974304

May 19th, 2022 - Transcatheter aortic valve implantation (TAVI) using the JenaValve Trilogy system met its primary safety and efficacy endpoints in the first real-world test of the novel valve in high-risk patients with severe aortic regurgitation (AR). Technical ...

SURTAVI at 5 Years Reinforces TAVR but Was It Long-term Enough?
https://www.medscape.com/viewarticle/962484

Nov 8th, 2021 - The SURTAVI trial has become the second major face-off between transcatheter and surgical aortic valve replacement (TAVR and SAVR, respectively), after PARTNER 2A, to show parity in 5-year clinical outcomes in patients with severe, symptomatic aor...

Infective Endocarditis With Stroke After TAVR Has 'Dismal' Prognosis
https://www.medscape.com/viewarticle/950702

May 6th, 2021 - Patients who suffer a stroke during hospitalization for infective endocarditis (IE) after transcatheter aortic valve replacement (TAVR) have a dismal prognosis, with more than half dying during the index hospitalization and two thirds within the f...

MHRA Highlights Risk of Heart Valve Regurgitation with Fluoroquinolones
https://www.medscape.com/viewarticle/943287

Dec 29th, 2020 - The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a drug safety update highlighting a small risk of heart valve regurgitation with the use of systemic and inhaled fluoroquinolones. The update follows a European review of ep...

New Valve Disease Guideline: Rethinking TAVR vs SAVR, MitraClip Indications
https://www.medpagetoday.com/cardiology/pci/90291

Dec 17th, 2020 - Transcatheter interventions get more love in updated valvular heart disease guidelines from the American College of Cardiology (ACC) and American Heart Association (AHA). Patients with severe aortic stenosis who have choices for intervention shoul...

see more →

Patient Education  6 results see all →